EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Heterozygosity of ALG9 in Association with Autosomal Dominant Polycystic Liver Disease

Melissa M Boerrigter iD, Renée Duijzer iD, René H M Te Morsche, Joost P H Drenth iD

Genes · 02.09.2023 · 14 (9) · 1755

DOI: 10.3390/genes14091755 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, online erschienen am 02.09.2023. Verfasst von Melissa M Boerrigter und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Research Institute for Medical Innovation, Radboud University Medical Center, 6525 GA Nijmegen, The Ne…. Hauptthemen laut MEDLINE: Polycystic Kidney, Autosomal Dominant, Liver Diseases, Cysts. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Radboud Institute for Molecular Life Sciences/Research Institute for Medical Innovation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

α-1,2-mannosyltransferase (ALG9) germline variants are linked to autosomal dominant polycystic kidney disease (ADPKD). Many individuals affected with ADPKD possess polycystic livers as a common extrarenal manifestation. We performed whole exome sequencing in a female with autosomal dominant polycystic liver disease (ADPLD) without kidney cysts and established the presence of a heterozygous missense variant (c.677G>C p.(Gly226Ala)) in ALG9. In silico pathogenicity prediction and 3D protein modeling determined this variant as pathogenic. Loss of heterozygosity is regularly seen in liver cyst walls. Immunohistochemistry indicated the absence of ALG9 in liver tissue from this patient. ALG9 expression was absent in cyst wall lining from ALG9- and PRKCSH-caused ADPLD patients but present in the liver cyst lining derived from an ADPKD patient with a PKD2 variant. Thus, heterozygous pathogenic variants in ALG9 are also associated with ADPLD. Somatic loss of heterozygosity of the ALG9 enzyme was seen in the ALG9 patient but also in ADPLD patients with a different genetic background. This expanded the phenotypic spectrum of ADPLD to ALG9.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Kidney, Autosomal DominantLiver DiseasesCystsHumansFemaleMannosyltransferasesMembrane Proteins

Stichwörter der Autor:innen

ADPLDALG9PCLDcyst wallpolycystic liver disease (PLD)whole exome sequencing

Substanzen

ALG9 protein, humanMannosyltransferasesMembrane Proteins

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Research Institute for Medical Innovation, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
  • European Reference Network RARE-LIVER, D-20246 Hamburg, Germany.

ORCID-Profile: Melissa M Boerrigter, Renée Duijzer, Joost P H Drenth

Förderung

  • Radboud Institute for Molecular Life Sciences/Research Institute for Medical Innovation

Zitieren

APA

Boerrigter, M. M., Duijzer, R., Te Morsche, R. H. M., & Drenth, J. P. H. (2023). Heterozygosity of ALG9 in Association with Autosomal Dominant Polycystic Liver Disease. Genes, 14(9), 1755. https://doi.org/10.3390/genes14091755

Vancouver

Boerrigter MM, Duijzer R, Te Morsche RHM, Drenth JPH. Heterozygosity of ALG9 in Association with Autosomal Dominant Polycystic Liver Disease. Genes. 2023;14(9):1755. doi:10.3390/genes14091755

BibTeX
@article{Boerrigter2023,
  author = {Boerrigter, Melissa M and Duijzer, Renée and Te Morsche, René H M and Drenth, Joost P H},
  title = {Heterozygosity of ALG9 in Association with Autosomal Dominant Polycystic Liver Disease},
  journal = {Genes},
  year = {2023},
  volume = {14},
  number = {9},
  pages = {1755},
  doi = {10.3390/genes14091755}
}
Kostenlos starten →